Clifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center, discusses findings from abstract S3-08, “Randomized comparison of adjuvant tamoxifen plus ovarian function suppression vs tamoxifen in premenopausal women with hormone receptor–positive early breast cancer: Analysis of the SOFT trial,” presented by Prudence Francis, MD.
William M. Sikov, MD, of Women and Infants Hospital, discusses abstract S4-05, ...
Lisa A. Carey, MD, of UNC Lineberger Comprehensive Cancer Center, offers her thoughts on abstract S1-09,
Ann H. Partridge, MD, MPH, of Dana-Farber Cancer Institute, on abstract S3-09, “...
Ann H. Partridge, MD, MPH, on Patient-Reported Outcomes From the SOFT Trial
Lisa A. Carey, MD, of the UNC Lineberger Comprehensive Cancer Center, discusses abstract S3-01,
Harry D. Bear, MD, PhD, of Massey Cancer Center, discusses abstract OT1-3-02, “...